Pierluigi Ramadori

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Anti Inflammatory

Top Venues

Oxidative medicine and cellular longevity

Nature reviews. Cancer

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Pierluigi Ramadori, Shing Kam, Mathias Heikenwalder
T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis. Hepatology (Baltimore, Md.) 75 (4) (2022)
Matthias Pinter, David James Pinato, Pierluigi Ramadori, Mathias F Heikenwälder
NASH and hepatocellular carcinoma: immunology and immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Xin Li, Pierluigi Ramadori, Dominik Pfister, Marco Seehawer, Lars Zender, Mathias F Heikenwälder
The immunological and metabolic landscape in primary and metastatic liver cancer. Nature reviews. Cancer 21 (9) (2021)
Chaofan Fan, Shing Kam, Pierluigi Ramadori
Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer. Cancers 13 (20) (2021)
Clarissa Gillmann, Gabor Pajor, Pierluigi Ramadori, Peter Albers, Ute Mons, Karen Steindorf, Susan Kentner, Michael Baumann
Solving problems is smart, preventing them is wise: Lessons learned from the 2nd International DKFZ Conference on Cancer Prevention. International journal of cancer 148 (12) (2021)
Pierluigi Ramadori, Hannah Drescher, Stephanie Erschfeld, Athanassios Fragoulis, Thomas W Kensler, Christoph Jan Wruck, Francisco Javier Cubero, Christian Trautwein, Konrad L Streetz, Daniela C Kroy
Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH. Oxidative medicine and cellular longevity 2017 (2017)